Interleukin-6 blockade for severe COVID-19
Mathilde Roumier, Romain Paule, Matthieu Groh, Alexandre Vallée, Félix Ackermann, for the Foch COVID-19 Study Group
doi: https://doi.org/10.1101/2020.04.20.20061861
Mathilde Roumier
1Department of Internal Medicine, Hôpital Foch, F-92151 Suresnes, France
MDRomain Paule
1Department of Internal Medicine, Hôpital Foch, F-92151 Suresnes, France
MDMatthieu Groh
1Department of Internal Medicine, Hôpital Foch, F-92151 Suresnes, France
MDAlexandre Vallée
2Diagnosis and Therapeutic Center, Hypertension and Cardiovascular Prevention Unit, AP-HP, Hôtel-Dieu Hospital, Paris-Descartes University, Paris, France
MDFélix Ackermann
1Department of Internal Medicine, Hôpital Foch, F-92151 Suresnes, France
MDArticle usage
Posted April 22, 2020.
Interleukin-6 blockade for severe COVID-19
Mathilde Roumier, Romain Paule, Matthieu Groh, Alexandre Vallée, Félix Ackermann, for the Foch COVID-19 Study Group
medRxiv 2020.04.20.20061861; doi: https://doi.org/10.1101/2020.04.20.20061861
Subject Area
Subject Areas
- Addiction Medicine (343)
- Allergy and Immunology (666)
- Anesthesia (180)
- Cardiovascular Medicine (2630)
- Dermatology (222)
- Emergency Medicine (397)
- Epidemiology (12183)
- Forensic Medicine (10)
- Gastroenterology (756)
- Genetic and Genomic Medicine (4071)
- Geriatric Medicine (387)
- Health Economics (679)
- Health Informatics (2628)
- Health Policy (998)
- Hematology (362)
- HIV/AIDS (845)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (431)
- Neurology (3840)
- Nursing (209)
- Nutrition (571)
- Oncology (2011)
- Ophthalmology (582)
- Orthopedics (239)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (74)
- Pathology (471)
- Pediatrics (1109)
- Primary Care Research (449)
- Public and Global Health (6504)
- Radiology and Imaging (1390)
- Respiratory Medicine (869)
- Rheumatology (401)
- Sports Medicine (341)
- Surgery (441)
- Toxicology (52)
- Transplantation (185)
- Urology (165)